REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT02651662 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-31 → 2026-04-29 3. primary completion date: 2026-05-31 → 2026-04-29
Clinical trial NCT02651662 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-31 → 2026-04-29 3. primary completion date: 2026-05-31 → 2026-04-29
Clinical trial NCT01692886: start date: 2012-08-01 → 2012-09-01.
Clinical trial NCT06450197: primary completion date: 2026-05-01 → 2026-04-30.
Clinical trial NCT06018337 updates: 1. completion date: 2028-07-01 → 2028-08-01 2. primary completion date: 2026-05-01 → 2026-06-01
Notification from Dominari Holdings Inc
Arch Capital Group Ltd. Announces Cash Tender Offers to Purchase up to a Capped Amount of Certain of Its Subsidiaries’ Debt Securities
$170 Billion in Border and Security Funding Highlights Growing Demand for AI-Powered Surveillance and Machine Vision Technologies
RenX Posts Record Delivery Quarter at Myakka City, Up 57%; Independent Drone Survey Verifies Approximately 185,000 Cubic Yards On-Site
Corsica Utility to Support Its Conservation Goals With Itron’s Smart Water Solution
Net Asset Value(s)